The Department of Hematology, in cooperation with the other departments of the German Medical Institute (GMI), offers the most modern approach to diagnosing and treating hematological diseases.
The most novel developments in molecular medicine are implemented in all treatment plans for all hematological diseases. These include:
• Benign hematological diseases, such as anemia, thrombocytopenia, and hemostatic disorders
• Hematological malignancies, such as leukemia, lymphoma, multiple myeloma, and myeloproliferative neoplasms.
Our upcoming Bone Marrow Transplant and New Cell Therapies Unit will be the first of its kind in Cyprus. It will cover cellular therapies for hematological and non-hematological diseases such as:
• Autologous and allogeneic hematopoietic cell transplants for hematological malignancies
• Autologous hematopoietic cell transplants for non-hematological malignancies and autoimmune diseases (e.g., for solid tumors, multiple sclerosis)
New cell therapies for the treatment of hematological malignancies (CAR-T cells) and inherited diseases (e.g., gene therapy for beta-thalassemia)
The Department of Hematology
The Department of Hematology
The Department of Hematology